Highlights of the 2023 Edition of the Meidian Guide Draft: Newly Added Testing Items
Release time:
2023-08-04 17:21
According to the highlights of the draft 2023 edition of the U.S. Clinical Practice Guidelines, the latest draft introduces several important new testing procedures. These newly added tests will help provide a more comprehensive assessment of patients' health conditions. They include genetic testing, microbiome assessment, and metabolite analysis. Genetic testing will enable physicians to identify genetic variations within patients, thus allowing them to develop more personalized treatment plans. Microbiome assessment, on the other hand, will facilitate research into the relationship between gut microbiota and overall health, offering more precise guidance for the treatment of intestinal disorders. Meanwhile, metabolite analysis can detect metabolic products in patients’ bodies, helping physicians gain a better understanding of their patients’ metabolic status. These newly introduced tests will give physicians more diagnostic and therapeutic options, providing patients with more precise medical care.
Relevant Information
Service hotline:
Company email:
Share
